TCAs versus placebo - National Center for Biotechnology Information

AGOSTI1991 (Published Data Only)
Agosti, V., Stewart, J. W., & Quitkin, F. M. (1991). Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants. Journal of Affective Disorders,
23, 35-41.
AGOSTI1993 (Published Data Only)
Agosti, V., Stewart, J. W., Quitkin, F. M., & Ocepek-Welikson, K. (1993). How symptomatic do depressed patients remain after benefiting from medication treatment? Comprehensive Psychiatry, 34,
182-186.
AGOSTI1999A (Published Data Only)
Agosti, V. (1999). Predictors of persistent social impairment among recovered depressed outpatients. Journal of Affective Disorders, 55, 215-219.
AGOSTI2002 (Published Data Only)
Agosti, V., Quitkin, F. M., Stewart, J. W., & McGrath, P. J. (2002). Somatization as a predictor of medication discontinuation due to adverse events. International Clinical Psychopharmacology, 17,
311-314.
AGOSTI2002A (Published Data Only)
Agosti, V. & McGrath, P. J. (2002). Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depression. Journal of Affective Disorders., 71, 113-120.
AINSLIE1965 (Published Data Only)
Ainslie, J.D., Jones, M. B., & Stiefel, J. R. (1965). Practical drug evaluation method: Imipramine in depressed outpatients. Archives of General Psychiatry, 12, 368-373.
ALEXOPOULOS2000
Alexopoulos, G. S., Meyers, B. S., Young, R. C., Kalayam, B., Kakuma, T., Gabrielle, M. et al. (2000). Executive dysfunction and long-term outcomes of geriatric depression. Archives of General
Psychiatry, 57, 285-290.
ANON1993H (Published Data Only)
How long should the elderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. Old Age Depression Interest Group. (1993). British
Journal of Psychiatry, 162, 175-182.
ANON1995H (Published Data Only)
Fluoxetine (1995). New Zealand Medical Journal, 108.
ANON2005F
Drug treatments for bipolar disorder: 1 - Acute manic or depressive episodes (2005). Drug & Therapeutics Bulletin, 43.
ANTON1994 (Published Data Only)
Anton, S. F., Robinson, D. S., Roberts, D. L., Kensler, T. T., English, P. A., & Archibald, D. G. (1994). Long-term treatment of depression with nefazodone. Psychopharmacology Bulletin, 30, 165-
169.
ARNOLD1981 (Published Data Only)
Arnold, S. E., Kahn, R. J., Faldetta, L. L., Laing, R. A., & McNair, D. M. (1981). Tricyclic antidepressants and peripheral anticholinergic activity. Psychopharmacology, 74, 325-328.
ASBERG1973
Asberg, M., Bertilsson, L., Tuck, D., Cronholm, B., & Sjoqvist, F. (1973). Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline.
Clinical Pharmacology & Therapeutics, 14, 277-286.
ASBERG1974
Asberg, M. (1974). Plasma nortriptyline levels--relationship to clinical effects. Clinical Pharmacology & Therapeutics, 16, 215-229.
ASHTON1978
Ashton, H., Millman, J. E., Telford, R., & Thompson, J. W. (1978). A comparison of some physiological and psychological effects of Motival (fluphenazine and nortriptyline) and diazepam in normal
subjects. British Journal of Clinical Pharmacology, 5, 141-147.
BAKISH1993A (Published Data Only)
Bakish, D., Lapierre, Y. D., Weinstein, R., Klein, J., Wiens, A., Jones, B. et al. (1993). Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder. Journal of Clinical
Psychopharmacology, 13, 409-414.
BAKISH1994 (Published Data Only)
Bakish, D., Ravindran, A., Hooper, C., & Lapierre, Y. (1994). Psychopharmacological treatment response of patients with a DSM-III diagnosis of dysthymic disorder. Psychopharmacology Bulletin,
30, 53-59.
71